US53630X2036
US53630X2036
Lipocine Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 14.18M EUR | 21.11M EUR | 59.73M EUR | 49.45M EUR |
Enterprise Value | -7.1M EUR | 16.13M EUR | 54.71M EUR | 44.25M EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -1.39x | -- | -- | -- |
Price to Sales | 9.04x | 13.45x | 29.83x | 26.27x |
Price to Book | 0.65x | 0.97x | 2.62x | 3.42x |
EV/Revenue | -4.52x | 10.27x | 27.33x | 23.5x |
EV/EBITDA | 0.57x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -48.94% | -53.02% | -16.82% | -15.76% |